Edition:
United States

Novus Therapeutics Inc (NVUS.OQ)

NVUS.OQ on NASDAQ Stock Exchange Capital Market

2.84USD
13 Dec 2018
Change (% chg)

-- (--)
Prev Close
$2.84
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
22,618
52-wk High
$8.61
52-wk Low
$2.60

Chart for

About

Novus Therapeutics, Inc., formerly Tokai Pharmaceuticals, Inc., is a pharmaceutical company. The Company is focused on the acquisition, development, and commercialization of ear, nose, and throat products. It has two platforms: OP-01 Foam Platform and OP-02 Surfactant Program. OP-01 is developed with the intent to be used as a... (more)

Overall

Beta: --
Market Cap(Mil.): $33.47
Shares Outstanding(Mil.): 6.94
Dividend: --
Yield (%): --

Financials

  NVUS.OQ Industry Sector
P/E (TTM): -- 31.13 34.39
EPS (TTM): -7.20 -- --
ROI: -67.10 15.55 14.96
ROE: -67.53 16.92 16.52

Earnings vs. Estimates